Page last updated: 2024-10-25

deferiprone and Optic Neuritis

deferiprone has been researched along with Optic Neuritis in 1 studies

Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.

Optic Neuritis: Inflammation of the optic nerve. Commonly associated conditions include autoimmune disorders such as MULTIPLE SCLEROSIS, infections, and granulomatous diseases. Clinical features include retro-orbital pain that is aggravated by eye movement, loss of color vision, and contrast sensitivity that may progress to severe visual loss, an afferent pupillary defect (Marcus-Gunn pupil), and in some instances optic disc hyperemia and swelling. Inflammation may occur in the portion of the nerve within the globe (neuropapillitis or anterior optic neuritis) or the portion behind the globe (retrobulbar neuritis or posterior optic neuritis).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khan, RS1
Baumann, B1
Dine, K1
Song, Y1
Dunaief, JL1
Kim, SF1
Shindler, KS1

Other Studies

1 other study available for deferiprone and Optic Neuritis

ArticleYear
Dexras1 Deletion and Iron Chelation Promote Neuroprotection in Experimental Optic Neuritis.
    Scientific reports, 2019, 08-12, Volume: 9, Issue:1

    Topics: Animals; Chelating Agents; Deferiprone; Encephalomyelitis, Autoimmune, Experimental; Female; Humans;

2019